Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-23

FDA Approved: CANDESARTAN CILEXETIL — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the Original Application for candesartan cilexetil by Zydus Lifesciences Limited, confirming a generic version of the antihypertensive agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • candesartan cilexetil (candesartan cilexetil)

Snippet

ORIG AP for CANDESARTAN CILEXETIL (CANDESARTAN CILEXETIL)